GlassScriptPhysician profile
Bruce T Rose
NPI 1861420077
$487.82
in general payments reported to CMS, 2019-2025
11 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73.44 · 2021: $11.36 · 2022: $90.28 · 2023: $125 · 2024: $80.02 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $312.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $123.83 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $71.16 | 2021-2025 | Fasenra, Airsupra |
| Glaxosmithkline, LLC. | $63.77 | 2023-2024 | Shingrix, Arexvy |
| Novo Nordisk INC | $62.51 | 2022-2025 | Ozempic |
| Davol INC. | $36.21 | 2023 | Arista Ah Flexitip |
| Boston Scientific Corporation | $34.77 | 2019 | |
| Lilly USA, LLC | $29.86 | 2023-2024 | Mounjaro, Trulicity |
| Exact Sciences Corporation | $20.98 | 2025 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $19.44 | 2025 | Thinprep 2000 Processor, Aptima |
| Stimwave Technologies Incorporated | $12.66 | 2019 | |
| Dynavax Technologies Corporation | $12.63 | 2023 | Heplisav-B |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Rose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.